Armistice Capital’s CRISPR Therapeutics CRSP Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-208,000	Closed	-$8.19M	–	235
2024 Q4	$8.19M	Buy	208,000 +8,000	+4%	+$315K	0.11%	98
2024 Q3	$9.4M	Buy	200,000 +1,643	+0.8%	+$77.2K	0.15%	93
2024 Q2	$10.7M	Buy	198,357 +6,357	+3%	+$343K	0.13%	85
2024 Q1	$13.1M	Buy	192,000 +24,000	+14%	+$1.64M	0.17%	84
2023 Q4	$10.5M	Sell	168,000 -432,012	-72%	-$27M	0.14%	78
2023 Q3	$27.2M	Buy	600,012 +100,012	+20%	+$4.54M	0.42%	45
2023 Q2	$28.1M	Sell	500,000 -324,000	-39%	-$18.2M	0.41%	47
2023 Q1	$37.3M	Sell	824,000 -212,000	-20%	-$9.59M	0.54%	40
2022 Q4	$42.1M	Buy	1,036,000 +112,000	+12%	+$4.55M	0.73%	31
2022 Q3	$60.4M	Sell	924,000 -76,000	-8%	-$4.97M	1.05%	20
2022 Q2	$60.8K	Sell	1,000,000 -24,000	-2%	-$1.46K	1.06%	25
2022 Q1	$64.3M	Buy	1,024,000 +132,000	+15%	+$8.29M	1.24%	14
2021 Q4	$67.6M	Buy	892,000 +512,000	+135%	+$38.8M	1.11%	18
2021 Q3	$42.5M	Buy	380,000 +222,000	+141%	+$24.8M	0.72%	31
2021 Q2	$25.6M	Buy	158,000 +2,000	+1%	+$324K	0.46%	57
2021 Q1	$19M	Buy	156,000 +84,000	+117%	+$10.2M	0.44%	55
2020 Q4	$11M	Sell	72,000 -132,000	-65%	-$20.2M	0.37%	65
2020 Q3	$17.1M	Buy	204,000 +16,000	+9%	+$1.34M	0.62%	50
2020 Q2	$13.8M	Sell	188,000 -48,000	-20%	-$3.53M	0.61%	55
2020 Q1	$10M	Buy	236,000 +88,000	+59%	+$3.73M	0.62%	49
2019 Q4	$9.01M	Sell	148,000 -116,000	-44%	-$7.07M	0.52%	46
2019 Q3	$10.8M	Buy	+264,000	New	+$10.8M	0.72%	36
2019 Q2	–	Sell	-80,000	Closed	-$2.86M	–	61
2019 Q1	$2.86M	Sell	80,000 -92,000	-53%	-$3.29M	0.16%	57
2018 Q4	$4.91M	Buy	+172,000	New	+$4.91M	0.37%	47
2018 Q3	–	Sell	-124,000	Closed	-$7.29M	–	77
2018 Q2	$7.29M	Buy	+124,000	New	+$7.29M	0.48%	46